Wall Street heads into a heavy earnings day on July 30 with the Federal Reserve's July 29 policy statement in the rearview and megacap technology results still to come. Chair Kevin Warsh's June 17 FOMC left the fed funds range at 3.50%-3.75% and said inflation risks had "eased substantially," and CME Group's FedWatch tool continues to imply roughly an 80% probability of zero cuts for the remainder of 2026. Against that steady-rates backdrop, sell-side analysts used Wednesday, July 29 to press a broad slate of pure Buy upgrades across autos, semiconductors, oilfield services, wholesale retail and managed care. Here are five Strong Buy candidates worth watching on Thursday, July 30.
Ford Motor (F) — Citigroup Sees Autos Turning
Ford is one of the largest U.S. automakers with a portfolio spanning full-size trucks, SUVs and its Model e electric-vehicle lineup, along with a growing Ford Pro commercial business. On July 29, Citigroup analyst upgraded Ford from Neutral to Buy with a $20 price target, arguing the earnings trough is behind the business and that pricing, mix and Ford Pro margins can drive multiple expansion into 2027. Piper Sandler's Alexander Potter reiterated Overweight at $17 the same day, while TD Cowen's Itay Michaeli kept Hold at $15 and RBC Capital's Tom Narayan held Sector Perform at $15.
Shares traded at $15.55 on July 29, up 3.94% on the session, with a market cap of $61.96 billion and a trailing P/E of 9.66 on EPS of $1.61. The 52-week range is $10.68 to $17.78, placing Ford near cycle highs. The consensus rating is Buy, with 5 of 15 tracked analysts bullish, an average price target of $15.29, a median of $15, a high of $20 and a low of $11.
Risks: Tariff policy on Mexico- and Canada-built vehicles remains unresolved, EV losses continue to weigh on segment margins, U.S. auto credit is tightening, and Wells Fargo's Colin Langan continues to see downside risk to earnings.
Texas Instruments (TXN) — Arete Calls Out an Upcycle
Texas Instruments is the world's largest producer of analog and embedded processing semiconductors, with meaningful capital-return capacity and a multi-year in-house wafer fab expansion nearly complete. On July 29, Arete Research analyst moved TXN from Neutral to Buy with a $405 price target, the highest on the Street, calling out an emerging analog upcycle as industrial and automotive customer inventories bottom. That constructive view sits alongside Rosenblatt's Kevin Cassidy at Buy $350 on July 24, JPMorgan's Harlan Sur at Overweight $340 on July 23 and Susquehanna's Christopher Rolland at Positive $340 on July 21.
Shares traded at $276.74 on July 29, essentially flat at -0.12%, with a market cap of $252.73 billion and a trailing P/E of 47.39 on EPS of $5.84. The 52-week range is $152.73 to $334.03. The consensus rating is Buy, with 12 of 20 tracked analysts bullish, an average target of $327.75, a median of $340, a high of $400 and a low of $225.
Risks: Analog cycle timing has proven longer than bulls expected, capex intensity remains elevated through 2026, competition from Chinese domestic suppliers is a structural pressure, and Morgan Stanley's Joseph Moore stays Underweight at $230 on continued gross-margin concerns.
Weatherford International (WFRD) — UBS Buys the Pullback
Weatherford International is a global oilfield services company with strong positions in production, intervention, drilling and evaluation product lines, and expanding digital-solutions revenue. On July 29, UBS analyst Josh Silverstein upgraded WFRD from Neutral to Buy and lifted his price target to $114 from $113, arguing that international upstream capex is stickier than U.S. shale and that free-cash-flow conversion is improving. Barclays' David Anderson reiterated Overweight at $151 on July 24, marking the high on the Street.
Shares traded at $83.60 on July 29, essentially flat, with a market cap of $5.99 billion and a trailing P/E of 13.08 on EPS of $6.39. The 52-week range is $52.70 to $113.15. The consensus rating is Strong Buy, with 5 of 6 tracked analysts bullish, an average target of $121.17, a median of $116.50, a high of $151 and a low of $107.
Risks: International rig counts remain sensitive to OPEC+ supply decisions, U.S. shale activity has decelerated, integration and cost discipline are ongoing tests, and Goldman Sachs' Atidrip Modak has maintained a Neutral rating at $107 with a more measured view on service pricing.
BJ's Wholesale Club (BJ) — Gordon Haskett Sees Comp Momentum
BJ's Wholesale Club is a membership-based warehouse retailer operating across the Eastern United States, with a growing private-label portfolio and expanding gasoline and grocery penetration. On July 29, Gordon Haskett upgraded BJ from Hold to Buy with a $115 price target, citing accelerating comparable-club sales, sticky membership renewals and a widening value gap against traditional grocers. Baird's Peter Benedict has held Outperform at $115 since November 24, 2025, DA Davidson's Michael Baker maintained Buy at $123 on August 25, 2025, and UBS's Mark Carden kept Buy at $125 the same day.
Shares closed at $99.15 on July 29, up 2.05% on the session, with a market cap of $12.66 billion and a trailing P/E of 22.74 on EPS of $4.36. The 52-week range is $83.21 to $110.92. The consensus rating is Buy, with 7 of 12 tracked analysts bullish, an average target of $106.67, a median of $105, a high of $125 and a low of $90.
Risks: Grocery gross margins are pressured by input costs, warehouse-club competition from Costco is intensifying, discretionary category demand has softened at lower-income cohorts, and JPMorgan's Christopher Horvers holds a Neutral at $98 that limits near-term upside from consensus.
Humana (HUM) — BofA Buys the Earnings Selloff
Humana is one of the largest U.S. managed-care organizations with a Medicare Advantage-focused footprint, expanding CenterWell primary-care clinics and specialty pharmacy services. On July 29, B of A Securities upgraded HUM from Neutral to Buy with a $500 price target, moving after a sharp same-day selloff on the company's Q2 update, and arguing that 2027 Medicare Advantage bid economics and cost-trend visibility should improve materially. Wells Fargo's Stephen Baxter had already upgraded to Overweight at $502 on July 13, and Deutsche Bank's George Hill moved to Buy at $441 on May 20, while Morgan Stanley's Erin Wright stays Underweight at $217.
Shares traded at $360.06 on July 29, down 7.37% following the Q2 report, with a market cap of $43.23 billion and a trailing P/E of 22.70 on EPS of $15.86. The 52-week range is $163.11 to $428.88. The consensus rating is Hold, with 4 of 15 tracked analysts bullish, an average target of $354.33, a median of $350, a high of $502 and a low of $249.
Risks: Medicare Advantage medical loss ratios remain elevated, 2027 bid outcomes are not yet known, star-rating volatility drives multi-year revenue variability, and Morgan Stanley's Wright continues to see policy and utilization risk framing meaningful downside from consensus.
Found this helpful? Share it with others.